Authors: Georgopapadakou, N Broxterman, H Cowman, A Kuritzkes, D Warnock, D

Citation: N. Georgopapadakou et al., Untitled, DRUG RESIST, 4(1), 2001, pp. 1-1

Authors: Schooley, RT Spino, C Kuritzkes, D Walker, BD Valentine, FT Hirsch, MS Cooney, E Friedland, G Kundu, S Merigan, TC McElrath, MJ Collier, A Plaeger, S Mitsuyasu, R Kahn, J Haslett, P Uherova, P deGruttola, V Chiu, S Zhang, B Jones, G Bell, D Ketter, N Twadell, T Chernoff, D Rosandich, M

Citation: Rt. Schooley et al., Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214, J INFEC DIS, 182(5), 2000, pp. 1357-1364

Authors: Smith, KY Valdez, H Landay, A Spritzler, J Kessler, HA Connick, E Kuritzkes, D Gross, B Francis, I McCune, JM Lederman, MM

Citation: Ky. Smith et al., Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy, J INFEC DIS, 181(1), 2000, pp. 141-147

Authors: Spear, GT Olinger, G Sullivan, BL Landay, AL Kessler, H Connick, E Kuritzkes, D St Clair, M Spritzler, J Wu, H Lederman, MM

Citation: Gt. Spear et al., Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons, AIDS RES H, 15(18), 1999, pp. 1713-1715